UOC
MTACU

UBS O'Connor’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

UBS O'Connor’s Portfolio MTACU Stock Details MTACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-182,500
Closed -$1.92M – 973
2020
Q4 		$1.92M Buy
+182,500
New +$1.9M 0.04% 361

Other funds holding MTACU

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

UBS O'Connor's MTACU Position: Q1 2021 in Review

UBS O'Connor sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2021, closing a stake of 182,500 shares — an estimated $1.92M sold.

UBS O'Connor first reported a position in MTACU in Q4 2020 and held it in 1 quarter. The position peaked at $1.92M in Q4 2020. 31 funds tracked by Wall St. Rank hold MTACU as of Q1 2021.

  • UBS O'Connor reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
  • UBS O'Connor sold 182,500 MedTech Acquisition Corporation Unit shares in Q1 2021, an estimated $1.92M.
  • UBS O'Connor first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 1 quarter.
  • UBS O'Connor's MedTech Acquisition Corporation Unit position peaked at $1.92M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2021.

Based on UBS O'Connor's 13F filing for Q1 2021, filed 14 May 2021.